Nuclear β-catenin immunoexpression in scars.

Area of Science:

• Dermatopathology
• Molecular pathology
• Immunohistochemistry

Background:

• Scars can histopathologically resemble superficial fibromatoses.
• Superficial fibromatoses exhibit nuclear beta-catenin immunoexpression.
• Genetic alterations in CTNNB1 or APC are not typically found in these tumors.

Purpose of the Study:

• To compare nuclear beta-catenin immunoexpression in scars versus superficial fibromatoses.
• To assess the diagnostic utility of beta-catenin staining in distinguishing these conditions.

Main Methods:

• Immunohistochemistry using an anti-beta-catenin antibody (clone 14).
• Analysis of 8 superficial fibromatoses and 22 scars.
• Classification of nuclear staining extent (negative, focal, diffuse) and intensity (weak, moderate, strong).

Main Results:

• Nuclear beta-catenin immunoexpression was observed in 95% of scars (fibroblasts/myofibroblasts), often diffuse and moderate to strong.
• 88% of superficial fibromatoses showed nuclear beta-catenin expression in lesional spindle cells.
• Normal papillary dermal fibroblasts consistently expressed nuclear beta-catenin, unlike reticular dermal fibroblasts.

Conclusions:

• Scars typically display nuclear beta-catenin expression patterns similar to superficial fibromatoses.
• Beta-catenin immunohistochemistry is not a suitable diagnostic tool for differentiating scars from superficial fibromatoses.
• Further markers may be needed to distinguish between these histopathologically similar entities.